| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |